Savan is the Founder and CEO of BioTrillion, Inc.
Previously, Savan spent the majority of his 15 year career in the Life Sciences industry working with hundreds of public and private corporations as a Healthcare Investment Banker at Citigroup, Deutsche Bank. From Analyst through Managing Director, he led ~40 M&A, IPO, and financing deals, totaling $35+ billion in value, and experienced many invaluable business and scientific lessons from his work with clients across the spectrum of drug, diagnostic, and device technologies. Some of these companies included Amgen, Anacor, Boston Scientific, Eli Lilly, Intermune, Map Pharma, Masimo, Medtronic, Omeros, Pacific Biosciences, and many others. While a Vice President at Deutsche Bank, Savan was selected to lead the firm's build-out of its Healthcare business into Asia, leading to IPO's of the two largest healthcare companies in China: Shanghai Pharma and Fosun Pharma. Savan began his career as a Bioengineer at Life Technologies.
Savan graduated with a M.S.E. in Bioengineering from the University of Pennsylvania and a B.S.E. in Bioengineering focused in Computer Science from the University of California at Berkeley.
After many years of academic and professional experience in the healthcare field, a deeply personal experience later in life gave Savan a new perspective into how much healthcare needed to change – his mother was abruptly diagnosed with stage 4 cancer. This compelled Savan to ask “where were all the signs” and “isn't there a better way,” which led to him returning to his Bioengineering roots and founding BioTrillion.
Anthony is a Computer Vision Engineer at BioTrillion. He was previously with Visio Impulse, where he applied novel Computer Vision techniques to enable user-search and detection of ground-earth objects via satellite imagery. Anthony earned a MS in Computer Science degree from University College London and a BS in Computer Science and Economics degrees from Harvey Mudd College of the Claremont Colleges. Throughout his academic career, he has focused on artificial intelligence, computer vision, and entrepreneurship and has spent years developing and applying deep learning models for image segmentation, object detection, and other optical based applications. Anthony is a California native and is passionate about enabling radically transformative innovations by intersecting Computer Vision with Consumer Healthcare.
Samir is a Biology major at the University of Oxford. He is an active member of the biotech and life sciences community in the UK’s Golden Triangle of Cambridge, London, and Oxford and has been devoting his interests and efforts to advancing biological innovations with digital technology. Recognizing San Francisco as a global hub of scientific and entrepreneurial activity, Samir took a year out of his Oxford degree to intern at BioTrillion.
Matthieu is currently an Intern at BioTrillion and concurrently earning his second Master's in Electrical and Computer Engineering major at Georgia Tech, focused on Machine Learning and Biotech. After earning his Bachelor and Master of Science from the École Centrale Paris, Matthieu took a gap year to intern around the world as a Data scientist and as a Management Consultant at BCG. Over the years, Matthieu has become passionate about contributing to the advancement of medical research through his technical skills.
Shawn is currently an Intern at BioTrillion while concurrently earning his degree in Electrical Engineering and Computer Science at the University of California, Berkeley. He’s passionate about utilizing mobile technologies to solve healthcare’s largest hurdles. While in high school, Shawn became a 2018 Apple Worldwide Developers Conference Scholar and developed a set of medical devices ranging from an app that helps users detect skin cancer to search and rescue software that automatically locates displaced victims on the ground. Shawn strives to continue advancing his knowledge and experiences to create technologies that are both accessible and affordable.
Dr. Kirk was at NVIDIA for over 20 years, and served in many roles, including Chief Scientist, Vice President of Architecture, and most recently, Fellow. Dr. Kirk received the Distinguished Alumni award from Caltech in 2009. He was elected in 2006 to the National Academy of Engineering (NAE) for his role in bringing high-performance graphics to personal computers. In 2002, he received the SIGGRAPH Computer Graphics Achievement Award for his role in bringing high-performance computer graphics systems to the mass market. Dr. Kirk is the inventor of more than 60 patents and patent applications relating to graphics design and has published more than 50 articles on graphics technology. He also co-authored the popular textbook “Programming Massively Parallel Processors.”
Dr. Kirk holds B.S. and M.S. degrees from MIT and M.S. and Ph.D. degrees in Computer Science from Caltech, with a minor in Computation and Neural Systems.
Dr. Kumar is a Lillian & Morrie Moss Chair of Excellence Professor in Computer Science at the University of Memphis. His research focuses on using mobile sensors for self-monitoring of health, wellness, and performance. Dr. Kumar's research group has developed computational models to infer human health and behaviors such as stress, conversation, smoking, craving, brushing, flossing, and drug use from wearable sensor data. He leads several large federally-funded multidisciplinary projects in mobile sensor big data funded by NIH, NSF, and IARPA (worth over $40 million). Dr. Kumar is currently Center Director and Lead PI of the NIH Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) that involve investigators in computing, engineering, behavioral science, and medicine from 17 universities. In 2010, he was named "Sensor Guru" by the Popular Science magazine as part of their profiling of America's Ten Brilliant Young scientists and is a frequent keynote speaker or presenter at universities, medical schools, federal agencies including at the White House, international conferences, and national meetings of experts.
Dr. Kumar holds a PhD in Computer Science from Ohio State and BS in Computer Science from the prestigious Indian Institute of Technology (IIT).
Dr. Su is a seasoned Bioengineer with over 20 years of experience in the medical device and pharmaceutical industry. His expertise includes combinational device and pharmaceutical formulation. Dr. Su spent the majority of his professional career at Biosensors International, where he rose through the ranks to Director of R&D, until the Company’s acquisition. He has extensive experience in taking conceptual R&D ideas to human clinical trial and finally to commercialization. He is inventor/co-inventor of 32 issued worldwide patents and 25 pending patent applications.
Dr. Su holds a Bachelor’s degree in Chemical Engineering, and Masters and PhD degrees in Biomedical Engineering.
Dr. Fontanella brings tremendous clinical experience from his years at the prestigious Memorial Sloan Kettering Cancer Center, as both a data science researcher and as Chief Resident in Medical Physics. Throughout his 10+ years of experience in a healthcare environment, he has developed a passion for developing quantitative methods for improving cancer patients’ treatment outcomes. His personal experiences of seeing close family members bravely battling deadly diseases has sparked a deep drive within him to apply his knowledge and experience towards the improvement of healthcare in the US through advanced machine learning techniques.
Dr. Fontanella graduated with a PhD in Biomedical Engineering from Duke University while studying under the mentorship of Mark Dewhirst, a renowned leader in the field of tumor microcirculation and targeted drug delivery. His thesis work involved in vivo observation of vascular radiation-response in tumors using optical techniques. He also holds a Masters degree in Electrical and Computer Engineering, with a focus in Optics, Photonics, and Image Processing.